Followers | 23 |
Posts | 2189 |
Boards Moderated | 0 |
Alias Born | 03/18/2013 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, February 03, 2023 1:08:42 PM
Make your selections below, using the options on the right side of the page.
That Per Wold-Olsen be removed from office as a director of the Company with immediate effect.
Non-Management Recommendation:For
1.
That Per Wold-Olsen be removed from office as a director of the Company with immediate effect.
Non-Management Recommendation:
For
For
Against
Abstain
That in the event any director is appointed after the Company's receipt of the general meeting requisition notice dated January 10, 2023, requiring the Company to convene the General Meeting, and prior to the General Meeting, each such director be removed from office as a director of the Company with immediate effect.
Non-Management Recommendation:For
2.
That in the event any director is appointed after the Company's receipt of the general meeting requisition notice dated January 10, 2023, requiring the Company to convene the General Meeting, and prior to the General Meeting, each such director be removed from office as a director of the Company with immediate effect.
Non-Management Recommendation:
For
For
Against
Abstain
That Patrice Bonfiglio, having consented to act, be appointed as an additional director of the Company with immediate effect.
Non-Management Recommendation:For
3.
That Patrice Bonfiglio, having consented to act, be appointed as an additional director of the Company with immediate effect.
Non-Management Recommendation:
For
For
Against
Abstain
That Paul Cohen, having consented to act, be appointed as an additional director of the Company with immediate effect.
Non-Management Recommendation:For
4.
That Paul Cohen, having consented to act, be appointed as an additional director of the Company with immediate effect.
Non-Management Recommendation:
For
For
Against
Abstain
That Mark DiPaolo, having consented to act, be appointed as an additional director of the Company with immediate effect.
Non-Management Recommendation:For
5.
That Mark DiPaolo, having consented to act, be appointed as an additional director of the Company with immediate effect.
Non-Management Recommendation:
For
For
Against
Abstain
That Keith L. Horn, having consented to act, be appointed as an additional director of the Company with immediate effect.
Non-Management Recommendation:For
6.
That Keith L. Horn, having consented to act, be appointed as an additional director of the Company with immediate effect.
Non-Management Recommendation:
For
For
Against
Abstain
That Odysseas Kostas, having consented to act, be appointed as an additional director of the Company with immediate effect.
Non-Management Recommendation:For
7.
That Odysseas Kostas, having consented to act, be appointed as an additional director of the Company with immediate effect.
Non-Management Recommendation:
For
For
Against
Abstain
That Louis Sterling III, having consented to act, be appointed as an additional director of the Company with immediate effect.
Non-Management Recommendation:For
8.
That Louis Sterling III, having consented to act, be appointed as an additional director of the Company with immediate effect.
Non-Management Recommendation:
For
For
Against
Abstain
That Diane E. Sullivan, having consented to act, be appointed as an additional director of the Company with immediate effect.
Non-Management Recommendation:For
9.
That Diane E. Sullivan, having consented to act, be appointed as an additional director of the Company with immediate effect.
Non-Management Recommendation:
For
For
Against
Abstain
CUSIP: 023111
Sorry, I could not respond to you yesterday, I used up my 15 Posts for the day.
Recent AMRN News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM